Trans fatty acids and coronary heart disease.
Ascherio
A
A
Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. alberto.ascherio@channing.harvard.edu
Katan
M B
MB
Zock
P L
PL
Stampfer
M J
MJ
Willett
W C
WC
D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000209:etiology*; D004041:Dietary Fats / Q000008:administration & dosage / Q000009:adverse effects; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage / Q000009:adverse effects*; D005227:Fatty Acids / Q000008:administration & dosage / Q000009:adverse effects; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D006801:Humans; D006865:Hydrogenation; D017270:Lipoprotein(a) / Q000097:blood; D012307:Risk Factors
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004041:Dietary Fats; D004042:Dietary Fats, Unsaturated; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D017270:Lipoprotein(a)